2 China-Focused ETFs For After the Trump-Xi Summit
As the U.S.-China AI race heats up despite tech leaders' growing calls for caution, the meeting between Presidents Trump and Xi in late September 2026 may have been more of an opportunity to reduce risks incrementally rather than a chance to fully reset the rivalry between the two nations.
FXI: Update As Presidents Trump And Xi Prepare To Meet
I reiterate my Buy rating on iShares China Large-Cap ETF, emphasizing its compelling value versus U.S. equities despite significant political risk. FXI trades at half the S&P 500's P/E (11.10 vs. 22.54), with a 1.98% yield and strong liquidity, but suffers from poor momentum and high perceived risk. The upcoming Trump-Xi summit presents a near-term catalyst; both leaders have incentives to reach mutually beneficial agreements, potentially igniting FXI shares.
FXI: Time To Take China Seriously. Start By Knowing This ETF.
I am initiating a small trading position in iShares China Large-Cap ETF (FXI) for diversification and potential decoupling from US tech-driven markets. FXI benefits from China's state-backed monetary interventions and AI ecosystem push, but is anchored by financials, not pure tech exposure. FXI trades at 13.3x trailing earnings, offering attractive relative valuation versus the S&P 500's 33x, despite recent underperformance.
Forget FXI. The South Korea Fund Beating China's AI Trade Charges 19% Less
The iShares China Large-Cap ETF (NYSEARCA:FXI) is the default way most U.S.
FXI And MCHI: China Is A Perfect Example Of A Value Trap
I reiterate my sell rating on Chinese equity ETFs FXI and MCHI, citing persistent macroeconomic and structural headwinds. Despite attractive 9x P/E valuations, Chinese stocks remain value traps due to falling profit margins, rising corporate leverage, and ongoing deflationary pressures. China's shift from real estate-driven growth to high-value exports is fraught with risk, as excess supply and weak domestic demand undermine recovery.
Banco Bilbao Vizcaya Argentaria S.A. Sells 165,037 Shares of iShares China Large-Cap ETF $FXI
Banco Bilbao Vizcaya Argentaria S.A. reduced its holdings in iShares China Large-Cap ETF (NYSEARCA:FXI) by 32.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 343,700 shares of the exchange traded fund's stock after selling 165,037 shares during the period. Banco
China consumer inflation hits three-year high as producer deflation eases
China's consumer inflation recorded the biggest jump in more than three years. Consumer price index rose 1.3% in February from a year earlier, beating economists' forecast for a 0.8% increase in a Reuters poll.
Chinese Stocks And The FXI After The Supreme Court Ruling On U.S. Tariffs
I reiterate a Buy rating on the iShares China Large-Cap ETF, citing compelling valuation and bullish technical momentum. FXI trades at a blended P/E of 13.27 versus SPY's 24.43 and yields 2.37%, reflecting both value and geopolitical risk. The recent Supreme Court tariff ruling triggered a bullish key reversal in FXI, highlighting resilience amid U.S.-China trade policy uncertainty.
What Lies Ahead for China ETFs in the New Year of the Horse?
China ETFs enter the Year of the Horse with cheap valuations, AI momentum and policy support, but property woes, weak consumption and geopolitics may keep volatility elevated.
FXI: Stocks Replace Real Estate
I upgraded iShares China Large-Cap ETF to Buy, citing robust local capital flows and policy support. FXI offers over 22% consensus upside and a 2% dividend yield, with key holdings out-yielding local deposits and bonds. Portfolio EPS growth is projected at 11% for 2026 and 15% for 2027, with a YE26 PE of 13x, yielding an attractive PEG of 1x.
China manufacturing activity expands for the first time since March, beating expectations
China's economy ended the year on a slightly less gloomy note as manufacturing, services and construction activity all improved in December.
FXI And MCHI: See Why China May Have Already Lost The AI Race
I reiterate a sell rating on assets that track the main Chinese indices, citing an unattractive risk-return profile and persistent macro headwinds. China is prioritizing technological leadership in AI over real economic growth, risking further economic slowdown and instability. FXI trades at 12x earnings, in line with its 5-year average, offering no compelling valuation discount despite heightened risks.
